Anti-Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis), Respiratory Diseases), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI102825

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Forecast Period	2026-2034
Historical Period	2021-2024
Unit	Value (USD billion)
Segmentation	By Drug Class Anti-inflammatory Biologics Non-steroidal Anti-inflammatory Drugs (NSAIDs) Corticosteroids
	By Application Autoimmune Inflammatory Diseases Rheumatoid Arthritis Psoriasis Others Respiratory Diseases Others
	By Route of Administration Oral Injection Topical Inhalation
	By Distribution Channel Hospital Pharmacy Retail Pharmacy Online Pharmacy
	By Geography North America (the U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe) Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East& Africa (South Africa, GCC and the Rest of Middle East & Africa)